Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza Vaccine T Cell Responses in Adults 65+
NCT04077424Phase 4Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Oct 2019
- Primary completion
- Feb 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Efluelda, Fluzone Trivalent, influenza vaccine in influenza, sponsored by Vanderbilt University Medical Center. Started Oct 2019; status: completed.
02
Drugs
EflueldaFluzone Trivalentinfluenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04077424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04077424.